Clinical Pharmacists Participate in Rational Drug Use Management by Informatization Clinical Pathway Under DRGs: A Case Study of Glycyrrhizic Acid Injection
10.13748/j.cnki.issn1007-7693.20224315
- VernacularTitle:DRGs下临床药师利用信息化临床路径参与合理用药管理：以静脉用甘草酸制剂为例
- Author:
Yangyang WANG
1
;
Yalan ZHU
1
;
Yiling HE
1
Author Information
1. Jinhua Municipal Central Hospital, Jinhua 321000, China
- Publication Type:Journal Article
- Keywords:
DRGs；clinical pharmacist;
clinical pathway；rational drug use；intravenous infusion
- From:
Chinese Journal of Modern Applied Pharmacy
2024;41(12):1729-1734
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE :To discuss the participation of clinical pharmacists in rational drug use management by informatization clinical pathway under diagnosis related groups(DRGs) background by taking glycyrrhizic acid injection as an example.
METHODS
Based on the PDCA cycle theory, the evaluation scheme was established to find the problems in the use of glycyrrhizic acid injection in Jinhua Municipal Central Hospital, and the necessity of glycyrrhizic acid injection in the pathway was determined according to the needs of diagnosis and treatment, and the elimination and maintenance were carried out. The rational rate of drug use and the changes of monitoring indexes were compared before and after intervention in the same period(Q2 2021 vs Q2 2022).
RESULTS
Compared with the same period in 2021, the rational use rate of glycyrrhizic acid injection increased to a certain extent in the second quarter of 2022, and the utilization rate, the number of intravenous administration per capita per day, the intensity of use and the average drug cost per case all decreased.
CONCLUSION
Under the background of DRGs, the participation of clinical pharmacists in rational drug use by informatization clinical pathway can reduce the irrational use of glycyrrhizic acid injection and reduce the hospital monitoring index.
